Indonesia’s Pharmaceutical Market Will Continue Rapid Growth to $12.6 Billion by 2020

The pharmaceutical market in Indonesia more than doubled from just under $3 billion in 2008 to reach approximately $7 billion in 2015 and is anticipated to increase further to $12.6 billion by 2020, driven primarily by the Indonesian government’s economic and healthcare initiatives. Indonesia’s pharmaceutical sector will be boosted by the establishment of a universal healthcare scheme, known as the Jaminan Kesehatan Nasional. This was launched in January 2014 with the aim of providing health insurance to 250 million Indonesian citizens by 2019, which would make it the world’s largest social health insurance. New economic policy packages, the high prevalence of infectious diseases, widespread generic drug supply, increasing affordability of healthcare products and the large over-the-counter medicines market will also help to drive growth in Indonesia’s pharmaceutical sector.

GlobalData’s “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia report provides information on Indonesia’s healthcare, regulatory, and reimbursement landscape, with annualized market data on the pharmaceutical and medical devices sectors from 2014 and forecast to 2020. It includes detailed analysis of the political and economic environment, covering economic indicators, demographics, and healthcare infrastructure and expenditure in Indonesia.

Published: Feb’16 – Single user price: $1,995

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s